AlgoSource manufactures products and active ingredients extracted from microalgae. It is part of the MAGNIFICENT project, a European consortium that is developing a new value chain for food, aquaculture and cosmetic ingredients made from microalgae. AlgoSource’s mission is to develop an extraction process chain for three strains of marine microalgae in order to isolate their proteins and lipids. It is in this context that Olivier Lépine, the co-founder and CEO of AlgoSource, called upon Capacités to establish a biorefinery process and to scale it up.
Key words
Linked expertise
“Capacités’s offer includes every stage of the extraction process on a pre-industrial scale.”
Could you tell us a bit about the challenges of the MAGNIFICENT project? What role did Capacités play?
“The MAGNIFICENT project is a European project which aims to develop and scale up marine microalgae refining processes in order to produce ingredients for cosmetics and food. The objective: to reduce microalgae production costs and to generate new market opportunities with high added values.
This project has two facets: on one hand, process development in a laboratory setting using new technologies; on the other hand, unit operation integration on a pre-industrial scale in order to establish technical feasibility and price, as well as to provide data for a life-cycle assessment (i.e., an environmental impact study).
AlgoSource, who was entrusted with scaling up the bead milling and tangential flow filtration parameters, is involved in the second facet, assisted by Capacités. Now it’s up to us to produce the pilot batches to be tested by our clients.”
What made you decide to outsource part of your R&D to Capacités?
“Well, we’ve been using the GEPEA laboratory – Capacités continuum for quite a while now. We are well acquainted with the Capacités team, made up of committed and motivated people supervised by a renowned Professor in microalgae science, as well as with their technical level in bioprocess.
The Capacités – GEPEA cluster is of great benefit to us. Capacités takes full advantage of the technical resources made available to them at the AlgoSolis R&D platform, and there’s one in particular that is quite unique in France although not yet in use: continuous bead milling. We need this equipment in order to validate the biorefinery processes on a pre-industrial scale.
In the exploratory phase, we worked alongside the GEPEA laboratory and Capacités to expand our theoretical analysis of bead mill use. We are still moving towards the pre-industrial scale-up with Capacités.
What we find interesting about Capacités’s offer is that it goes beyond merely delivering a technology: it includes every stage of the extraction process on a pre-industrial scale. Capacités optimises the process, demonstrates its feasibility on an industrial scale, quantifies the results and provides the relevant data to the MAGNIFICENT project partners.
We have very high expectations when it comes to process optimisation with respect to yield, cost and data quality. Capacités has both the experience and the analytical tools to get the job done.”
Following on from your collaboration, what was your impression of Capacités?
“Their biorefinery know-how allowed them to act quickly, to organise their work efficiently and to adapt to any unforeseen events swiftly.”
OUR PROJECTS
These projects may also interest you
GLS is an engineering company specialised in water treatment and, as such, frequently designs wastewater treatment plants. In that context, it must comply with the legal limits of nitrogen and phosphorous content in the treated wastewater discharged from the plant.
As part of an industrial ecology initiative aimed at mitigating waste heat and industrial effluents rich in CO2 that are produced by cement plants, ADEME (French Agency for Environment and Energy Management) funded the project “CIMENTALGUE”.
SARA recognized Capacités’ experience in strain screening and trusted them with collecting algae strains from their natural environment, isolating them and determining their cultivation parameters.
ezCOL BV called upon experts in bioprocess engineering from Capacités to scale up the microalgal biomass production and provide the volume necessary for a clinical trial.
This site uses cookies and gives you control over what you want to enable
